Echocardiographically Detected Left Ventricular Hypertrophy: Prevalence and Risk Factors
The Framingham Heart Study
- DANIEL LEVY, M.D.;
- KEAVEN M. ANDERSON, Ph.D.;
- DANIEL D. SAVAGE, M.D., Ph.D.;
- WILLIAM B. KANNEL, M.D.;
- JANE C. CHRISTIANSEN, M.P.H.; and
- WILLIAM P. CASTELLI, M.D.
Abstract
The prevalence of and risk factors associated with echocardiographically determined left ventricular hypertrophy were examined in 4976 participants in the Framingham Heart Study (age, 17 to 90 years). Left ventricular hypertrophy was detected in 356 men (16%) and 513 women (19%). Prevalence increases dramatically with age (P < 0.001), with 33% of men and 49% of women age 70 or older affected. A significant association between blood pressure and left ventricular hypertrophy is present and occurs at levels of systolic pressure below 140 mm Hg (age adjusted, P < 0.001). There is a ninefold (women) to tenfold (men) increase from leanest to most obese group (age adjusted, P < 0.001). In multivariate analysis, age, blood pressure, obesity, valve disease, and myocardial infarction are independently associated in both sexes. We conclude that left ventricular hypertrophy is a common echocardiographic finding for which several risk factors can be identified. These findings support weight reduction and blood pressure control for prevention or regression of this condition.
Article and Author Information
-
▸From the Framingham Heart Study, Framingham, Massachusetts; the Division of Epidemiology and Clinical Applications, National Heart, Lung and Blood Institutes, Bethesda, Maryland; and the Divisions of Epidemiology and Preventive Medicine, Boston University School of Medicine, Boston, Massachusetts.
-
▸Requests for reprints should be addressed to Daniel Levy, M.D.; Framingham Heart Study, 118 Lincoln Street; Framingham, MA 01701.
- © 1988 American College of Physicians
RSS Feeds









